查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1338972

小儿惊厥治疗药物市场,份额,规模,趋势,行业分析报告:按治疗药物类别,治疗类型,製剂,给药途径,分销渠道,地区，2023-2032年

Infantile Spasm Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Class (Anticonvulsants, Corticosteroids, Others); By Drug Type; By Dosage, By Route of Administration; By Distribution Channel; and Region 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，儿科癫痫治疗市场预计将达到 1.8185 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

市场正在见证突破性的药物开发，包括仿製药。例如，MSN Labs 推出了印度第一个通用版本的氨己烯酸 (Viganext)，以粉末形式给药。最近的技术进步在小儿惊厥的预先治疗和预防治疗领域尤其引人注目，包括开发非侵入性自动癫痫发作检测设备，以帮助早期发现癫痫发作，提供了更好的解决方案。在COVID-19时代，随着远距医疗和远距会诊的出现，小儿惊厥治疗药物市场出现了激增，因为它在坐月子时代被广泛使用。这种巨大的需求源自于其简单舒适的筛检、来自世界各地的咨商等优势。

每年 12 月第一週在世界各地举办的小儿惊厥意识週等宣传活动的存在和数量不断增加，有助于对市场产生正面影响。此外，研发相关投入集中，导致新药研发增加，新药和高配伍性药物的需求增加。根据世界银行的数据，全球 GDP 的 2.63% 投资于研究和开发市场上现有治疗方法的更好替代方案。

小儿惊厥治疗药物市场报告亮点

抗惊厥药占销售额的最大份额。这是因为治疗过程中疗效高且患者易于耐受。

促肾上腺皮质激素部分占据最大的销售份额，因为其安全性和有效性而受到临床医生和处方医生的青睐，作为小儿惊厥的治疗方法。

液体药物由于其具有儿科患者给药方便、患者依从性高、起效快等优势，占据了最大的市场份额。

医院细分占了最大的市场份额，因为儿科惊厥药物需要医生在场，而且医院药房比其他分销形式更方便。

北美因其较早采用技术、更好的医疗基础设施以及不断推动产品创新而占据市场主导地位。

该市场的主要参与者包括 Lundbeck、Mallinckrodt Pharmaceuticals、Market Catalyst Pharmaceuticals、GW Pharmaceuticals、Retropin、Valerion Therapeutics、Orphelia Pharma、Insys Therapeutics 和 Anavex Life Sciences。

目录

第 1 章 简介

第二章执行摘要

第三章研究方法论

第四章全球小儿惊厥治疗市场洞察

  • 小儿惊厥治疗 - 行业概况
  • 小儿惊厥治疗药物市场动态
    • 驱动因素和机遇
      • 新生儿小儿癫痫发作的发生率增加
      • 加大政府支持力度
    • 限制因素和挑战
      • 药品费用昂贵
  • PESTLE分析
  • 小儿惊厥药产业发展趋势
  • COVID-19 感染的影响分析

第五章全球儿科惊厥治疗药物市场（依药物类别）

  • 主要发现
  • 介绍
  • 抗惊厥药
  • 皮质类固醇
  • 其他

第六章全球小儿惊厥治疗药物市场（依药物类型）

  • 主要发现
  • 介绍
  • 氨己烯酸
  • 促肾上腺皮质激素
  • 其他（三期）

第七章全球小儿惊厥治疗药物市场（按製剂）

  • 主要发现
  • 介绍
  • 坚硬的
  • 液体

第八章全球儿科惊厥治疗药物市场（依给药途径）

  • 主要发现
  • 介绍
  • 口服
  • 肠外
  • 其他

第九章全球小儿惊厥治疗药物市场（依通路）

  • 主要发现
  • 介绍
  • 医院药房
  • 零售药店
  • 网上药店

第10章全球小儿惊厥治疗药物市场（按地区）

  • 主要发现
  • 介绍
    • 2019-2032 年小儿惊厥治疗药物市场评估（按地区）
  • 儿科癫痫药物市场—北美
    • 北美：小儿惊厥药物市场，依药物类别，2019-2032
    • 北美：2019-2032 年儿科癫痫药物市场（依给药途径）
    • 北美：2019-2032 年小儿惊厥治疗药物市场（依治疗类型）
    • 北美：儿科癫痫药物市场（按处方），2019-2032 年
    • 北美：小儿惊厥治疗药物市场，依通路划分，2019-2032
    • 儿科癫痫治疗药物市场—美国
    • 儿科癫痫药物市场—加拿大
  • 小儿惊厥治疗市场 - 欧洲
    • 欧洲：小儿惊厥药物市场，依药物类别，2019-2032
    • 欧洲：儿科癫痫药物市场，依给药途径划分，2019-2032 年
    • 欧洲：小儿惊厥治疗药物市场，依治疗类型，2019-2032
    • 欧洲：2019-2032年小儿惊厥治疗药物市场（按製剂）
    • 欧洲：小儿惊厥治疗药物市场，依通路划分，2019-2032
    • 儿科癫痫药物市场 - 英国
    • 小儿惊厥治疗市场—法国
    • 小儿惊厥治疗市场—德国
    • 小儿惊厥治疗市场—义大利
    • 小儿惊厥治疗市场—西班牙
    • 小儿惊厥治疗市场 - 荷兰
    • 小儿惊厥治疗药物市场—俄罗斯
  • 小儿惊厥治疗药物市场 - 亚太地区
    • 亚太地区：2019-2032 年小儿惊厥药物市场（依治疗类别）
    • 亚太地区：2019-2032 年儿科癫痫药物市场（依给药途径）
    • 亚太地区：小儿惊厥治疗药物市场，依治疗类型，2019-2032
    • 亚太地区：小儿惊厥药物市场，依准备状况，2019-2032
    • 亚太地区：2019-2032 年小儿惊厥治疗药物市场（依通路）
    • 小儿惊厥治疗药物市场—中国
    • 小儿惊厥治疗药物市场—印度
    • 小儿惊厥治疗药物市场—日本
    • 小儿惊厥治疗市场 - 马来西亚
    • 小儿惊厥治疗药物市场—印度尼西亚
    • 小儿惊厥治疗药物市场－韩国
  • 小儿惊厥治疗药物市场—中东和非洲
    • 中东和非洲：2019-2032 年小儿惊厥药物市场（依治疗类别）
    • 中东和非洲：2019-2032 年儿科癫痫药物市场（依给药途径）
    • 中东和非洲：2019-2032 年小儿惊厥治疗药物市场（依治疗类型）
    • 中东和非洲：2019-2032 年小儿惊厥药物市场（依准备情况）
    • 中东和非洲：2019-2032 年小儿惊厥治疗药物市场（依通路）
    • 小儿惊厥治疗市场—沙乌地阿拉伯
    • 小儿惊厥治疗药物市场—阿拉伯联合大公国
    • 小儿惊厥治疗药物市场 - 以色列
    • 儿科癫痫药物市场—南非
  • 小儿惊厥治疗药物市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年小儿惊厥药物市场（依药物类别）
    • 拉丁美洲：2019-2032 年儿科癫痫药物市场（依给药途径）
    • 拉丁美洲：2019-2032 年小儿惊厥治疗药物市场（依治疗类型）
    • 拉丁美洲：2019-2032 年小儿惊厥药物市场（依准备程度）
    • 拉丁美洲：2019-2032 年小儿惊厥治疗药物市场（依通路）
    • 小儿惊厥治疗药物市场—墨西哥
    • 小儿惊厥治疗市场 - 巴西
    • 小儿惊厥治疗市场—阿根廷

第十一章竞争格局

  • 扩张和收购分析
    • 扩张
    • 获得
  • 伙伴关係/协作/协议/揭露

第十二章公司简介

  • Lundbeck
  • Mallinckrodt Pharmaceuticals
  • Catalyst Pharmaceuticals
  • GW Pharmaceuticals
  • Retrophin
  • Valerion Therapeutics
  • Orphelia Pharma
  • Insys Therapeutics
  • Anavex Life Sciences Corp
Product Code: PM3416

The infantile spasm therapeutics market size is expected to reach USD 181.85 million by 2032, according to a new study by Polaris Market Research. The report "Infantile Spasm Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Class (Anticonvulsants, Corticosteroids, Others); By Drug Type; By Dosage, By Route of Administration; By Distribution Channel; and Region 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Market has witnessed some revolutionary drug developments including generic drugs, for e.g., MSN Labs launched India's first generic Vigabatrin (Viganext) that is to be administered as a powder. The recent technological advancements particularly in advance treatment and preventive treatment of Infantile Spasm Therapeutics, like development of non-invasive automated seizure detection device that help in early detection of seizure to provide better solutions for to treat the disorder. Due to presence of telemedicine and teleconsultation, during the times of COVID-19, Infantile Spasm Therapeutics market has seen a jump as it was widely used during the times of lockdown. This huge demand was seen due to the advantages of easy and comfortable check-up, consultation from across the globe amongst others.

The presence and increase of awareness campaigns like that of Infantile Spasm Therapeutics Awareness Week every first week of December across the globe contribute to positively impacting the market. Also, the growing demand for novel and compliant drugs is made possible by an increasing concentration on investments associated to research and development, which leads to an increase in new drug development. According to World Bank data, 2.63% of global GDP is invested in research and development of better alternatives to the drugs available in the market.

Infantile Spasm Therapeutics Market Report Highlights

The anticonvulsants segment accounted for the largest revenue share. This is due to its higher efficacy and ease of tolerance in patients undergoing treatment

Adrenocorticotropic hormone segment accounted to hold largest revenue share as it is preferred by the clinicians and prescribers to treat Infantile Spasm Therapeutics owing to its safety and efficacy making it the drug of choice

Liquid segment accounted for largest market share due to its advantages like ease of administration in infantile patients, high patient compliance, and rapid onset of action

Hospital Pharmacy segment account for a largest market share owing to the reason that Infantile Spasm Therapeutics requires treatment in presence of a medical practitioner and, hospital pharmacies provide convenience as compared to other modes of distribution

North America dominated the market as there is more early acceptance of techniques, better and more developed healthcare infrastructure and constant drive for product innovation.

The major players in the market include Lundbeck, Mallinckrodt Pharmaceuticals, Catalyst Pharmaceuticals, GW Pharmaceuticals, Retrophin, Valerion Therapeutics, Orphelia Pharma, Insys Therapeutics, & Anavex Life Sciences.

Polaris Market Research has segmented the Infantile Spasm Therapeutics market report based on therapeutic class, dosage, route of administration, distribution channel, drug type, and region:

Infantile Spasm Therapeutics Market, Therapeutic Class Outlook (Revenue - USD Million, 2019 - 2032)

  • Anticonvulsants
  • Corticosteroids
  • Others

Infantile Spasm Therapeutics Market, Drug Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Vigabatrin
  • Adrenocorticotropic Hormone
  • Others (Phase III)

Infantile Spasm Therapeutics Market, Dosage Outlook (Revenue - USD Million, 2019 - 2032)

  • Solid
  • Liquid

Infantile Spasm Therapeutics Market, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral
  • Parenteral
  • Others

Infantile Spasm Therapeutics Market, Distribution Channel Outlook (Revenue - USD Million, 2019 -2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Infantile Spasm Therapeutics Market, Region Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Infantile Spasm Therapeutics Market Insights

  • 4.1. Infantile Spasm Therapeutics - Industry Snapshot
  • 4.2. Infantile Spasm Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of infantile spasms in newborns
      • 4.2.1.2. Increasing government supports
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of treatment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Infantile Spasm Therapeutics Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Infantile Spasm Therapeutics Market, by Therapeutic Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • 5.3. Anticonvulsants
    • 5.3.1. Global Infantile Spasm Therapeutics Market, by Anticonvulsants, by Region, 2019-2032 (USD Million)
  • 5.4. Corticosteroids
    • 5.4.1. Global Infantile Spasm Therapeutics Market, by Corticosteroids, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Infantile Spasm Therapeutics Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Infantile Spasm Therapeutics Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • 6.3. Vigabatrin
    • 6.3.1. Global Infantile Spasm Therapeutics Market, by Vigabatrin, by Region, 2019-2032 (USD Million)
  • 6.4. Adrenocorticotropic Hormone
    • 6.4.1. Global Infantile Spasm Therapeutics Market, by Adrenocorticotropic Hormone, by Region, 2019-2032 (USD Million)
  • 6.5. Others (Phase III)
    • 6.5.1. Global Infantile Spasm Therapeutics Market, by Others (Phase III), by Region, 2019-2032 (USD Million)

7. Global Infantile Spasm Therapeutics Market, by Dosage

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • 7.3. Solid
    • 7.3.1. Global Infantile Spasm Therapeutics Market, by Solid, by Region, 2019-2032 (USD Million)
  • 7.4. Liquid
    • 7.4.1. Global Infantile Spasm Therapeutics Market, by Liquid, by Region, 2019-2032 (USD Million)

8. Global Infantile Spasm Therapeutics Market, by Route of Administration

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • 8.3. Oral
    • 8.3.1. Global Infantile Spasm Therapeutics Market, by Oral, by Region, 2019-2032 (USD Million)
  • 8.4. Parenteral
    • 8.4.1. Global Infantile Spasm Therapeutics Market, by Parenteral, by Region, 2019-2032 (USD Million)
  • 8.5. Others
    • 8.5.1. Global Infantile Spasm Therapeutics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Infantile Spasm Therapeutics Market, by Distribution Channel

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 9.3. Hospital Pharmacy
    • 9.3.1. Global Infantile Spasm Therapeutics Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Million)
  • 9.4. Retail Pharmacy
    • 9.4.1. Global Infantile Spasm Therapeutics Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
  • 9.5. Online Pharmacy
    • 9.5.1. Global Infantile Spasm Therapeutics Market, by Online Pharmacy, by Region, 2019-2032 (USD Million)

10. Global Infantile Spasm Therapeutics Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Infantile Spasm Therapeutics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 10.3. Infantile Spasm Therapeutics Market - North America
    • 10.3.1. North America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.3.2. North America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.3.3. North America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.3.4. North America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.3.5. North America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.3.6. Infantile Spasm Therapeutics Market - U.S.
      • 10.3.6.1. U.S.: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.3.6.2. U.S.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.3.6.3. U.S.: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.3.6.4. U.S.: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.3.6.5. U.S.: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.3.7. Infantile Spasm Therapeutics Market - Canada
      • 10.3.7.1. Canada: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.3.7.2. Canada.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.3.7.3. Canada: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.3.7.4. Canada: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.3.7.5. Canada: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 10.4. Infantile Spasm Therapeutics Market - Europe
    • 10.4.1. Europe: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.4.2. Europe.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.4.3. Europe: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.4.4. Europe: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.4.5. Europe: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.6. Infantile Spasm Therapeutics Market - UK
      • 10.4.6.1. UK: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.6.2. UK.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.6.3. UK: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.6.4. UK: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.6.5. UK: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.7. Infantile Spasm Therapeutics Market - France
      • 10.4.7.1. France: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.7.2. France.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.7.3. France: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.7.4. France: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.7.5. France: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.8. Infantile Spasm Therapeutics Market - Germany
      • 10.4.8.1. Germany: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.8.2. Germany.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.8.3. Germany: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.8.4. Germany: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.8.5. Germany: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.9. Infantile Spasm Therapeutics Market - Italy
      • 10.4.9.1. Italy: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.9.2. Italy.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.9.3. Italy: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.9.4. Italy: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.9.5. Italy: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.10. Infantile Spasm Therapeutics Market - Spain
      • 10.4.10.1. Spain: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.10.2. Spain.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.10.3. Spain: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.10.4. Spain: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.10.5. Spain: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.11. Infantile Spasm Therapeutics Market - Netherlands
      • 10.4.11.1. Netherlands: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.11.2. Netherlands.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.11.3. Netherlands: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.11.4. Netherlands: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.11.5. Netherlands: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.12. Infantile Spasm Therapeutics Market - Russia
      • 10.4.12.1. Russia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.12.2. Russia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.12.3. Russia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.12.4. Russia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.12.5. Russia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 10.5. Infantile Spasm Therapeutics Market - Asia Pacific
    • 10.5.1. Asia Pacific: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.5.2. Asia Pacific.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.5.3. Asia Pacific: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.5.4. Asia Pacific: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.5.5. Asia Pacific: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.6. Infantile Spasm Therapeutics Market - China
      • 10.5.6.1. China: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.6.2. China.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.6.3. China: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.6.4. China: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.6.5. China: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.7. Infantile Spasm Therapeutics Market - India
      • 10.5.7.1. India: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.7.2. India.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.7.3. India: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.7.4. India: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.7.5. India: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.8. Infantile Spasm Therapeutics Market - Japan
      • 10.5.8.1. Japan: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.8.2. Japan.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.8.3. Japan: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.8.4. Japan: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.8.5. Japan: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.9. Infantile Spasm Therapeutics Market - Malaysia
      • 10.5.9.1. Malaysia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.9.2. Malaysia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.9.3. Malaysia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.9.4. Malaysia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.9.5. Malaysia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.10. Infantile Spasm Therapeutics Market - Indonesia
      • 10.5.10.1. Indonesia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.10.2. Indonesia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.10.3. Indonesia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.10.4. Indonesia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.10.5. Indonesia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.11. Infantile Spasm Therapeutics Market - South Korea
      • 10.5.11.1. South Korea: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.11.2. South Korea.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.11.3. South Korea: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.11.4. South Korea: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.11.5. South Korea: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 10.6. Infantile Spasm Therapeutics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.6.2. Middle East & Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.6.3. Middle East & Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.6.4. Middle East & Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.6.5. Middle East & Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.6.6. Infantile Spasm Therapeutics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.6.6.2. Saudi Arabia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.6.6.3. Saudi Arabia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.6.6.4. Saudi Arabia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.6.6.5. Saudi Arabia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.6.7. Infantile Spasm Therapeutics Market - UAE
      • 10.6.7.1. UAE: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.6.7.2. UAE.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.6.7.3. UAE: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.6.7.4. UAE: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.6.7.5. UAE: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.6.8. Infantile Spasm Therapeutics Market - Israel
      • 10.6.8.1. Israel: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.6.8.2. Israel.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.6.8.3. Israel: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.6.8.4. Israel: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.6.8.5. Israel: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.6.9. Infantile Spasm Therapeutics Market - South Africa
      • 10.6.9.1. South Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.6.9.2. South Africa.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.6.9.3. South Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.6.9.4. South Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.6.9.5. South Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 10.7. Infantile Spasm Therapeutics Market - Latin America
    • 10.7.1. Latin America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.7.2. Latin America.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.7.3. Latin America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.7.4. Latin America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.7.5. Latin America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.7.6. Infantile Spasm Therapeutics Market - Mexico
      • 10.7.6.1. Mexico: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.7.6.2. Mexico.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.7.6.3. Mexico: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.7.6.4. Mexico: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.7.6.5. Mexico: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.7.7. Infantile Spasm Therapeutics Market - Brazil
      • 10.7.7.1. Brazil: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.7.7.2. Brazil.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.7.7.3. Brazil: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.7.7.4. Brazil: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.7.7.5. Brazil: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.7.8. Infantile Spasm Therapeutics Market - Argentina
      • 10.7.8.1. Argentina: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.7.8.2. Argentina.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.7.8.3. Argentina: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.7.8.4. Argentina: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.7.8.5. Argentina: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Lundbeck
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Mallinckrodt Pharmaceuticals
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Catalyst Pharmaceuticals
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. GW Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Retrophin
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Valerion Therapeutics
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Orphelia Pharma
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Insys Therapeutics
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Anavex Life Sciences Corp
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development

List of Tables

  • Table 1 Global Infantile Spasm Therapeutics Market, by Therapeutic Class, by Region, 2019-2032 (USD Million)
  • Table 2 Global Infantile Spasm Therapeutics Market, by Drug Type, by Region, 2019-2032 (USD Million)
  • Table 3 Global Infantile Spasm Therapeutics Market, by Dosage, by Region, 2019-2032 (USD Million)
  • Table 4 Global Infantile Spasm Therapeutics Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
  • Table 5 Global Infantile Spasm Therapeutics Market, by Route of Administration, by Region, 2019-2032 (USD Million)
  • Table 6 North America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 7 North America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 8 North America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 9 North America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 10 North America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 11 U.S.: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 12 U.S.: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 13 U.S.: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 14 U.S.: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 15 U.S.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 16 Canada: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 17 Canada: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 18 Canada: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 19 Canada: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 Canada: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 21 Europe: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 22 Europe: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 23 Europe: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 24 Europe: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 25 Europe: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 26 Germany: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 27 Germany: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 28 Germany: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 29 Germany: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 30 Germany: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 31 France: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 32 France: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 33 France: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 34 France: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 France: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 36 UK: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 37 UK: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 38 UK: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 39 UK: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 40 UK: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 41 Italy: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 42 Italy: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 43 Italy: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 44 Italy: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 45 Italy: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 46 Netherlands: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 47 Netherlands: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 48 Netherlands: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 49 Netherlands: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Netherlands: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 51 Spain: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 52 Spain: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 53 Spain: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 54 Spain: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 55 Spain: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 56 Russia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 57 Russia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 58 Russia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 59 Russia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 60 Russia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 61 Asia Pacific: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 62 Asia Pacific: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 63 Asia Pacific: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 64 Asia Pacific: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 Asia Pacific: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 66 China: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 67 China: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 68 China: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 69 China: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 70 China: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 71 Japan: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 72 Japan: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 73 Japan: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 74 Japan: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 75 Japan: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 76 India: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 77 India: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 78 India: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 79 India: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 India: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 81 Indonesia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 82 Indonesia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 83 Indonesia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 84 Indonesia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 85 Indonesia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 86 Malaysia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 87 Malaysia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 88 Malaysia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 89 Malaysia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 90 Malaysia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 91 South Korea: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 92 South Korea: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 93 South Korea: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 94 South Korea: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 95 South Korea: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 96 Latin America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 97 Latin America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 98 Latin America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 99 Latin America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 100 Latin America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 101 Brazil: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 102 Brazil: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 103 Brazil: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 104 Brazil: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 105 Brazil: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 106 Mexico: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 107 Mexico: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 108 Mexico: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 109 Mexico: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 110 Mexico: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 111 Argentina: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 112 Argentina: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 113 Argentina: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 114 Argentina: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 115 Argentina: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 116 Middle East & Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 117 Middle East & Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 118 Middle East & Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 119 Middle East & Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 120 Middle East & Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 121 UAE: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 122 UAE: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 123 UAE: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 124 UAE: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 125 UAE: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 126 Saudi Arabia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 127 Saudi Arabia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 128 Saudi Arabia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 129 Saudi Arabia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 130 Saudi Arabia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 131 South Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 132 South Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 133 South Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 134 South Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 135 South Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 136 Israel: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 137 Israel: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 138 Israel: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 139 Israel: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 140 Israel: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Infantile Spasm Therapeutics Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutic Class
  • Figure 7. Global Infantile Spasm Therapeutics Market, by Therapeutic Class, 2021 & 2030 (USD Million)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Infantile Spasm Therapeutics Market, by Drug Type, 2021 & 2030 (USD Million)
  • Figure 10. Market by Dosage
  • Figure 11. Global Infantile Spasm Therapeutics Market, by Dosage, 2021 & 2030 (USD Million)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Infantile Spasm Therapeutics Market, by Distribution Channel, 2021 & 2030 (USD Million)
  • Figure 14. Market by Route of Administration
  • Figure 15. Global Infantile Spasm Therapeutics Market, by Route of Administration, 2021 & 2030 (USD Million)